Organelle upkeep, secretion control and cell removal may independently extend life
Mitophagy in surviving parenchymal cells, secretion control in living senescent fibroblasts and antigen-dependent senescent cell removal may each yield lasting functional and lifespan gains; loss of a branch's distinct benefit when the other processes are constrained would reject their independence.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Rhythm or programme
Organelle maintenance
The processes that maintain cellular organelles
Where this hypothesis actsOrganelles in surviving parenchymal cells
Hypotheses on this target 1
Inhibition
Activation
Function preservation1
Feedback restoration
Rhythm restoration
Direct measurement

What is proposed
Function preservation
Support organelle maintenance
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible lasting functional benefits across multiple systems and increased lifespan
From the recordM обслуживает органеллы сохраняющихся паренхиматозных клеток.

Senescent cell
Senescent fibroblasts
Fibroblasts in a senescent state
Where this hypothesis actsLiving senescent fibroblasts producing harmful secretions
Hypotheses on this target 7
Function preservation2
Senolysis2
Senomorphic suppression1
Clearance restoration1
Reprogramming
Population balance

What is proposed
Senomorphic suppression
Suppress harmful secretion from senescent fibroblasts
With whatNot stated in the record
HowSuppress secretion while keeping the fibroblasts alive; the specific technique is not stated
Possible result
Possible improved function and survival even with mitophagy flux and senescent cell numbers held constant
From the recordR уменьшает вредную секрецию живых сенесцентных фибробластов.

Senescent cell
Senescent cells
Cells in a senescent state
Where this hypothesis actsSenescent cells that impair tissue repair even when their secretion is suppressed
Hypotheses on this target 4
Function preservation1
Senolysis3
Senomorphic suppression
Clearance restoration
Reprogramming
Population balance

What is proposed
Senolysis
Remove senescent cells that impair tissue repair
With whatNot stated in the record
HowUse antigen-dependent cytotoxicity requiring antigen presentation by the senescent cells
Possible result
Possible lasting functional benefits across multiple systems and increased lifespan
From the recordуспешное C требует представления антигенов сенесцентными клетками и антиген-зависимой цитотоксичности.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Longer life might come from several independently useful repairs, even when the processes that drive aging reinforce one another. The unexpected move is to make one repair depend on targeted immune recognition: removing troublesome cells is proposed to require those cells to display identifying fragments that allow immune cells to kill them. This is a hypothesis generated by the pipeline, not a measured finding.
- In the first proposed route, maintenance of internal cell structures supports surviving tissue cells and independently improves lasting function and survival.
- In the second proposed route, reduced harmful release from living senescent connective-tissue cells independently improves function and survival while those cells remain present.
- In the third proposed route, cells continue to obstruct tissue repair even after their harmful release has been suppressed.
- Those obstructing cells display identifying molecular fragments that enable immune cells to recognize and kill them.
- Their removal relieves the proposed obstruction to repair and independently improves lasting function and survival.
A workshop can lose output because its tools are damaged, a machine leaks fumes, or an idle machine blocks the work area. Fixing the tools, stopping the fumes, and clearing the obstruction could each help while leaving the other problems in place.
Where the picture breaks: The picture assumes three separable problems. Whether the biological processes are separable, whether each improves lifespan, and whether removal requires immune recognition are precisely the claims still awaiting tests.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.
Rests on: The goal adopts the possibility that a shared cause connects otherwise different forms of age-related decline.
AssumptionThe goal assumes that at least some interacting aging processes have a shared cause whose modification could produce benefits across several systems; it does not establish a particular cause.
- Goal pillarstep 02 of 04
The intended output is a collection of life-extension ideas that work through genuinely different causes.
Rests on: The master question requests ideas for interventions that could benefit several systems through a causal target.
Stated in the chain - Gap questionstep 03 of 04
The number of distinct ideas would be determined by separately switching intervening processes off and restoring them, then checking which interventions retain distinct, lasting benefits for several systems and lifespan.
Rests on: The preceding goal requires distinguishing ideas by their causes; this stage makes that distinction depend on controlled interruption and restoration of the proposed processes.
Stated in the chain - Hypothesisstep 04 of 04
Three independent routes are proposed: maintaining organelles, the working structures inside surviving tissue cells; reducing harmful secretion, the release of substances, from living senescent fibroblasts, connective-tissue cells in a persistent state of arrested division; and removing cells that obstruct repair even after their harmful secretion is suppressed. The removal route is proposed to require antigen presentation, the display of identifying molecular fragments on a cell’s surface, and antigen-dependent cytotoxicity, immune killing directed by recognition of those fragments. Each route is predicted to provide a distinct functional and lifespan benefit that the other two cannot replace.
Rests on: The chain’s requirement for separately interruptible benefits supplies the proposed independence test. The endpoint assigns a different causal role to each route and explicitly borrows its immune-recognition requirement from cancer immunology, the study of immune responses to cancer; that borrowing is a proposed dependency rather than evidence that it operates here.
Stated in the chain
What is carried, and what is not. Screened sources address aspects of all three proposed routes, but not their independence: S1 in Redox Biology (2026) reports increased mitophagy, the selective removal of mitochondria, cells’ energy-converting structures, alongside improved condition of aged heart muscle cells, without establishing longer life; S7 in Nature Communications (2026) reports that substances released by senescent human fibroblasts promoted cancer-cell growth, movement and invasion, without establishing an independent benefit from reducing that release during aging; and S9 in Aging (2011) describes delayed tissue disorders following removal of selected cells in mice with a premature-aging condition, without testing lifespan or the proposed immune-recognition requirement. No supplied source establishes the full sequence, three independently sufficient routes, or the claim that every pair misses a distinct functional and lifespan benefit.S1S7S9
Where the reasoning is carried by something unstated · 1
- Master question. The goal assumes that at least some interacting aging processes have a shared cause whose modification could produce benefits across several systems; it does not establish a particular cause.
How a result here could mislead · 3
- A survival gain after immune-mediated cell removal could reflect fewer cancer deaths rather than improved repair and function across aging tissues. What closes it: The organism-level test must distinguish causes of death and measure sustained function in several systems alongside survival. The supplied proposal explicitly excludes reduced cancer mortality alone from its success criterion.
- An apparent independent benefit from reducing harmful release could actually come from increased mitochondrial removal or fewer senescent cells if the supposedly fixed processes drift during the experiment. What closes it: The rate of mitochondrial removal and the number of senescent cells must be measured throughout the relevant period, alongside harmful release, function and survival. Conditions for treating those quantities as fixed must be specified before interpreting the result; the supplied material gives no thresholds or verification schedule.
- Loss of benefit after blocking molecular-fragment display could be attributed to failed cell removal even if the manipulation changes the target cells’ harmful behavior directly. Conversely, persistent benefit could appear to refute the dependency when display was never effectively blocked. What closes it: The test must verify loss and restoration of fragment display, measure recognition-dependent killing and actual cell removal, and check whether the manipulation changes harmful release or repair obstruction without removal. The proposed maintenance and secretion-reduction interventions must also be assessed under the same conditions, as the prediction requires.
What would make this wrong. The three-route claim would fail if, with the intended changes verified and a common success criterion fixed in advance, one route provided no independent lasting functional and survival benefit when the other two processes were restricted. A particularly discriminating failure would be loss of the secretion-reduction benefit when mitochondrial removal and senescent-cell number were successfully held fixed. The proposed immune dependency would separately fail if cell removal and its lasting benefit persisted despite verified suppression of target-cell antigen presentation. These outcomes would reject parts of this hypothesis without automatically establishing any one rival.
What it would change. If the hypothesis held, the search for broadly useful life-extension interventions would need to retain three causally distinct ideas within this candidate set: collapsing them into one shared repair process would discard independent benefits. Any pair would miss a reproducible benefit supplied by the third route. Even then, the supplied material does not specify the species, intervention identities, treatment duration or numerical success criteria for the decisive organism-level test, and a positive result in that system would not by itself establish longer human life or exhaust the possible targets.
Sources read · 10
CHK1 activates mitophagy to attenuate cardiac aging via inhibiting AHSA1-ubiquitination. · Redox biology · 2026
“In our study, we observed that CHK1 overexpression in senescent cardiomyocytes robustly augmented mitophagy, resulting in reduced ROS accumulation, mitigation of ROS-induced DNA damage and apoptosis, improved mitochondrial respiratory efficiency, and normalization of aberrant mitochondrial morphology.”
Does not settle: Источник описывает поддержание качества митохондрий в сенесцентных кардиомиоцитах и эффекты в старых мышах. Он не устанавливает продление жизни, не рассматривает снижение вредной секреции живых сенесцентных фибробластов, удаление клеток, представление антигенов или антиген-зависимую цитотоксичность, а также не проверяет необходимость набора из трёх представителей.
Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy. · Acta pharmacologica Sinica · 2023
“We showed that BBR and THBru treatment significantly mitigated diastolic dysfunction and cardiac remodeling in D-gal-induced aging mice.”
Does not settle: Источник поддерживает только идею M в модели старения сердца у мышей и в неонатальных кардиомиоцитах мыши. Он не устанавливает продление жизни, применимость к сохраняющимся паренхиматозным клеткам в целом, идеи R и C, их независимость, достаточность трёх представителей или требование антигенного представления и антиген-зависимой цитотоксичности для C.
Astragalus polysaccharide alleviated hepatocyte senescence via autophagy pathway. · The Kaohsiung journal of medical sciences · 2022
“APS reduced reactive oxygen species levels, inhibited apoptosis and pyroptosis, and promoted mitophagy via AMPK/mTOR pathway to alleviate hepatocyte senescence in vitro and in vivo.”
Does not settle: Источник описывает поддержание митохондриального гомеостаза и уменьшение старения гепатоцитов в клеточных линиях и у старых мышей. Он не устанавливает продление жизни, независимость трёх идей, эффекты R или C, а также требование представления антигенов и антиген-зависимой цитотоксичности для удаления клеток.
Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice. · Redox biology · 2021
“These results suggest that AKG increased myocardial mitophagy and reduced ROS production and cellular apoptosis under pressure overload.”
Does not settle: Источник рассматривает АКГ при вызванной давлением сердечной дисфункции у мышей и кардиомиоцитов; он не устанавливает продление жизни, независимость трёх идей, эффекты на сенесцентные фибробласты или антиген-зависимое удаление клеток.
Cellular senescence and acute kidney injury. · Pediatric nephrology (Berlin, Germany) · 2022
“Interestingly, genetic and pharmacological elimination of senescent cells partially prevents fibrosis but does not protect kidney function.”
Does not settle: Источник не устанавливает три независимые идеи, их минимальных представителей, влияние на продолжительность жизни, подавление секреции сенесцентных фибробластов или необходимость представления антигенов и антиген-зависимой цитотоксичности.
Heart Failure: Lipid Metabolism Disorders Driving Cellular Senescence Through a Vicious Cycle, and Possible Intervention Strategies. · Frontiers in bioscience (Landmark edition) · 2026
“The senescence-associated secretory phenotype (SASP) promotes a pro-senescent tissue microenvironment, thereby disrupting the normal metabolic balance and creating a vicious cycle that seriously affects heart structure and function.”
Does not settle: Абстракт не устанавливает самостоятельные эффекты M, R и C на продолжительность жизни или функции, не описывает сенесцентные фибробласты, устранение клеток при подавленной секреции, представление антигенов или антиген-зависимую цитотоксичность.
Time-resolved multiomics profiling reveals chromatin O-GlcNAc modification promotes senescence-associated transcriptional program. · Nature communications · 2026
“OIS-affected LU-RAS/KD-WT cells significantly stimulated the expansion, migration and invasion of A549 lung cancer cells through the secretion of SASP components.”
Does not settle: Источник показывает в модели сенесценции первичных человеческих фибробластов, что секреция компонентов секреторного фенотипа сенесцентных клеток стимулировала злокачественные свойства клеток A549. Он не устанавливает продление жизни, самостоятельный эффект вмешательства R на тканевое восстановление или старение, а также роли M и C, представления антигенов и антиген-зависимой цитотоксичности.
Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer. · Cancer research · 2026
“Senolytic therapies targeting the pro-survival BCL2 and IAP pathways upregulated after docetaxel-induced senescence effectively killed senescent tumor cells through multiple cell death pathways, remodeling the inflammatory SASP to repolarize myeloid phenotypes and potentiate CD8+ T cell activation to further block tumor growth and suppress metastasis.”
Does not settle: This abstract concerns therapy-induced senescent prostate cancer cells in cell lines and mouse tumor models. It does not establish organelle maintenance in parenchymal cells, secretion reduction in senescent fibroblasts, removal of cells that impair tissue repair despite suppressed secretion, antigen presentation by senescent cells, antigen-dependent cytotoxicity, independent lifespan effects, or the sufficiency of three representatives.
“Using a BubR1 progeroid mouse background designed for inducible elimination of p16 Ink4a -positive senescent cells, the authors demonstrate that in tissues in which p16 Ink4a contributes to the acquisition of age-related pathologies (i.e., adipose tissue, skeletal muscle and eye), life-long removal of p16 Ink4a -expressing cells significantly delays onset of these pathologies.”
Does not settle: Источник описывает удаление p16 Ink4a-положительных клеток в прогероидной мышиной модели, но не устанавливает три независимые идеи или достаточность трёх представителей. Он не сообщает, что устранение клеток требует представления антигенов сенесцентными клетками либо антиген-зависимой цитотоксичности, и не проверяет подавленную секрецию, восстановление тканей или продолжительность жизни.
From cancer immunosurveillance to cancer immunotherapy. · Immunological reviews · 2007
“We here discuss the immunological consequences of cellular senescence and apoptosis in the context of tumorigenesis.”
Does not settle: Аннотация не устанавливает, что сенесцентные клетки представляют антигены и что их устранение требует антиген-зависимой цитотоксичности. Она также не оценивает M, R или C, тканевое восстановление, продолжительность жизни либо достаточность набора из трёх представителей.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
How many distinct ways of extending life remain when targets are tested by disabling and restoring shared biological steps?
Original wording · exactly as the pipeline generated it
Сколько причинно самостоятельных идей «серебряных пуль» содержит проверяемый набор мишеней, если раздельное выключение и восстановление посредников должно определить, какие воздействия остаются различимыми по длительной пользе нескольким системам и продолжительности жизни?
What this question is asking
The question concerns how many genuinely separate routes to longer life are represented by a collection of biological targets. It asks whether switching off and then restoring mediators—the biological steps through which an intervention produces its effects—can distinguish interventions by their lasting benefits across several body systems and their effects on lifespan. Interventions would be compared over the same long observation period, and renaming an intervention or combining equivalent descriptions would not change the count. The question assumes that these dependency tests can support such a count, while allowing that shared mediators and limits on the benefit available may make different interventions look equivalent. The supplied material does not identify the complete target collection or specify that common observation period.
- Biological target
- A component or process that an intervention is intended to change. Different target names do not by themselves establish different routes to a benefit.
- Intervention
- A deliberate change, such as exercise, altered food intake, or disabling a gene, whose effects are assessed. Here, interventions are compared by their biological dependencies and lasting outcomes.
- Mediator and biological dependency
- A mediator is an intermediate biological step through which an intervention affects an outcome. An outcome depends on that step when disrupting it prevents the relevant effect in the tested setting; this does not establish that the step alone can produce the effect.
- Disabling and restoration
- Disabling reduces or removes a biological component's activity; restoration brings that component or its activity back. The question uses these changes to examine which effects depend on which steps.
- Causally independent routes and causal equivalence
- These describe whether interventions work through distinguishable chains of biological effects or can be grouped as the same route under a stated rule. They are proposed categories for counting, and the supplied material does not provide a complete rule for assigning them.
- Ceiling on benefit
- A limit beyond which a measured benefit no longer increases. Such a limit could make different interventions look similar, but its role in the intended target collection is not established.
- Muscle stem cells and activation
- Muscle stem cells are cells involved in maintaining and repairing muscle. Activation is their transition from a resting state toward activity involved in repair; S5 concerns their ability to make that transition in old mice.
- Cyclin D1
- A protein involved in controlling a cell's progression toward division. S5 identifies its restoration as necessary for recovery of the muscle stem-cell activation ability described there.
- Genes and genetically altered model
- Genes are inherited instructions that influence biological functions. A genetically altered model is an organism with an inherited change used to study a process; S6 concerns a particular worm model rather than all forms of reduced food intake.
- Autophagy
- A group of processes through which cells break down and recycle their own material. S6 concerns the requirement for this activity in the intestine in one worm lifespan model.
- Dietary restriction
- Reduced food intake or availability relative to a comparison condition. It covers different experimental arrangements; S6 concerns one genetic model of it.
- Insulin sensitivity
- How strongly the body responds to insulin, a hormone that helps regulate blood sugar. S8 measures changes in this response rather than lifespan.
- Oxygen-dependent metabolism
- The chemical processes through which cells use oxygen to help obtain energy. S8 reports indicators of these processes, which are measurements of selected features rather than a complete account of how the interventions work.
- Littermates
- Animals born in the same litter. The supplied S7 excerpt uses such animals as the comparison for mice lacking the candidate target.
Separate disabling and restoration of mediators can determine which interventions remain causally distinguishable by long-term benefits across several systems and lifespan, allowing a count that is unchanged by renaming or combining equivalent descriptions.
A mediator is a biological step between an intervention and its effects; disabling it tests whether an effect depends on that step, while restoring it examines whether the effect returns. The question assumes that these tests can sort a collection of interventions into genuinely different ways of producing lasting benefits and longer life. If that assumption holds, the count would reflect biological differences rather than the number of labels attached to targets.
S5 reports that recovery of activation ability in old mouse muscle stem cells depends on restoration of Cyclin D1. S6 reports that inhibiting cellular recycling in the intestine prevents the long lifespan of a particular worm model of restricted food intake. These support narrower claims about dependence on particular biological steps. Neither establishes a method for counting independent routes across a complete target collection using both disabling and restoration, a shared long-term comparison, benefits across several systems, and lifespan.S5S6
The same question asked without the part nothing read establishes:
- Which interventions in the target collection remain distinguishable in lasting benefits across several body systems and lifespan after shared biological steps are disabled and restored?
- What do the read sources establish about whether the candidate interventions depend on the same biological steps for their benefits?
- Several targets reduce to fewer routes If the dependency tests showed that differently named interventions produced their lasting benefits through the same route, those names would not establish separate opportunities to extend life. Treating every target as independent would then overcount the possibilities under the question's proposed counting rule.
- Several routes remain distinguishable If interventions retained different dependencies and different lasting effects after the tests, combining their descriptions would conceal biological differences. Under the question's proposed rule, those distinguishable routes would count separately.
- The tests leave the count unresolved If shared steps or a ceiling on measurable benefit made different routes produce indistinguishable results, the tests would not uniquely determine the count. An apparent match in outcomes would then leave open whether the interventions were equivalent or whether the comparison could not distinguish them.
An intervention may affect a target, which changes a mediator, which then changes how a body system functions. If several interventions depend on the same mediator, counting their names separately could overstate the number of independent opportunities to extend life. Conversely, similar measured benefits do not establish that the interventions work through the same route. Mistaking short-term improvement in one tissue for lasting benefits across several systems would also assign an intervention a broader effect than the supplied findings establish.
S-узлы описывают клеточные и иммунные механизмы уровней RL-1 и RL-2; метод проверки зависимостей доступен, причинные классы не подсчитаны.
Число самостоятельных идей, устойчивое к переименованию и объединению эквивалентных описаний, с различимыми прогнозами на общем хроническом горизонте.
Число названных мишеней неизвестным образом соотносится с числом самостоятельных возможностей продления жизни; общие посредники и насыщение могут скрывать различия.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
В наборе содержатся три самостоятельные идеи с минимальными представителями {M}, {R} и {C}; разбиение имеет вид {{M},{R},{C}}. M обслуживает органеллы сохраняющихся паренхиматозных клеток. R уменьшает вредную секрецию живых сенесцентных фибробластов. C устраняет клетки, нарушающие тканевое восстановление даже при подавленной секреции. Неожиданная необходимая зависимость третьей идеи заимствована из противоопухолевой иммунологии: успешное C требует представления антигенов сенесцентными клетками и антиген-зависимой цитотоксичности. Три представителя достаточны для охвата трёх независимых ответов; любой набор из двух пропускает один воспроизводимый функциональный и жизненный выигрыш.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Каждое одиночное воздействие проходит общий критерий успеха и сохраняет часть пользы при специфическом ограничении двух других процессов. Для C подавление представления антигенов клетками-мишенями устраняет удаление клеток и длительный эффект; возврат представления антигенов восстанавливает оба результата. M и R сохраняют пользу в тех же условиях. Особенно различающий результат: R улучшает функции и выживаемость при экспериментально фиксированных потоке митофагии и числе сенесцентных клеток.
Would tell it apart from at least one rival. The prediction specifies observable loss and restoration of effects, retained benefit under the same conditions, and improved function and survival with two processes held fixed. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Представление пептидов и антиген-зависимую цитотоксичность можно измерять в совместных культурах. В организме нужно отделять удаление сенесцентных клеток от противоопухолевого действия: снижение только опухолевой смертности при отсутствии многосистемного функционального выигрыша не удовлетворяет критерию.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Каждое одиночное воздействие проходит общий критерий успеха и сохраняет часть пользы при специфическом ограничении двух других процессов. Для C подавление представления антигенов клетками-мишенями устраняет удаление клеток и длительный эффект; возврат представления антигенов восстанавливает оба результата. M и R сохраняют пользу в тех же условиях. Особенно различающий результат: R улучшает функции и выживаемость при экспериментально фиксированных потоке митофагии и числе сенесцентных клеток.
- Rival 01 of 03What would separate them
Restoring mitochondrial renewal may account for all lasting benefits of the tested interventions predicts: При подтверждённом удалении сенесцентных клеток и снижении их секреции мягкое выключение митофагии только в сохраняющихся паренхиматозных клетках полностью устраняет длительную пользу C и R. Возврат митофагии восстанавливает пользу. Напротив, изолированное M сохраняет функциональный и жизненный выигрыш при экспериментальном удержании числа сенесцентных клеток и их воспалительной секреции около исходного уровня. Такой результат отличает единственный достаточный элемент {M} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.
- Rival 02 of 03What would separate them
Organelle renewal and senescent cell clearance may provide independent lasting benefits predicts: После выравнивания завершённого потока митофагии R перестаёт давать дополнительный длительный эффект. C сохраняет пользу при умеренном специфическом снижении M; M сохраняет пользу при снижении C. Возврат соответствующего посредника восстанавливает только его ветвь. Изотопное отслеживание переработки материала показывает два независимо изменяемых продуктивных потока. В отличие от гипотезы 01, C способен приносить пользу при ограниченном M; в отличие от гипотезы 03, R не сохраняет отдельного эффекта при фиксированном M; в отличие от гипотезы 04, одиночные M и C проходят общий критерий успеха.
- Rival 03 of 03What would separate them
Mitochondrial upkeep and senescent cell removal may jointly be required for longer life predicts: Из семи активных сочетаний общий критерий успеха проходят только M+C и M+R+C; добавление R к M+C не улучшает результат сверх заранее заданной границы эквивалентности. Ни M, ни C по отдельности не достигают критерия даже при подтверждённом воздействии на мишень и при нескольких допустимых уровнях интенсивности. Специфическое выключение любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. Одиночная достаточность M, ожидаемая в гипотезе 01, или самостоятельная достаточность C, ожидаемая в гипотезах 02 и 03, опровергает этот набор.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.